Skip to main content
Clinical Trials/ACTRN12616000750482
ACTRN12616000750482
Recruiting
N/A

In patients with rheumatoid arthritis and inflamed atlantoaxial joint, is intra-articular steroid injection,compared with systemic steroid administration effective and safe?

Diab Fuad Hetta0 sites60 target enrollmentJune 7, 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
atlantoaxial joint arthritis in rheumatoid patients
Sponsor
Diab Fuad Hetta
Enrollment
60
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 7, 2016
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Diab Fuad Hetta

Eligibility Criteria

Inclusion Criteria

  • Patients with rheumatoid arthritis with MRI findings of atlantoaxial joint inflammation and failure of resolution after 2 weeks systemic steroid administration

Exclusion Criteria

  • Coagulopathy, allergy to contrast material, pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, Not Recruiting
Phase 1
Patients with rheumatoid arthritis and synovitis treated with ultrasound guided intraarticular or intramuscular glucocorticoid injection - A randomised, double-blind, controlled study (Panguian)Treatment of synovitis among rheumatoid arthritis patientsMedDRA version: 21.0Level: PTClassification code 10042868Term: SynovitisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
EUCTR2017-003425-15-DKVidencenter for Reumatologi og Rygsygdomme, Rigshospitalet100
Not Yet Recruiting
N/A
Mannose-binding lectin (MBL) deficiency is more frequent in rheumatoid arthritis patients with coexistant bronchiectasis than in patients with rheumatoid arthritis alone or bronchiectasis alone.Rheumatoid arthritisBronchiectasisInflammatory and Immune System - Rheumatoid arthritisRespiratory - Other respiratory disorders / diseases
ACTRN12611000877987Krista Makin150
Completed
N/A
Clinical outcome in patients with rheumatoid arthritis switched to tumor nesrosis factor blockers after tocilizumab or abataceptrheumatoid arthritis
JPRN-UMIN000016950Osaka Medical College50
Recruiting
N/A
Rheumatoid Arthritis Patients rePort Onset Reactivatioarthritisrheumatoid arthritis10023213
NL-OMON30946Erasmus MC, Universitair Medisch Centrum Rotterdam150
Completed
N/A
Follow-up study of patients with rheumatoid arthritis who treated infliximab for 1 year and did not reach a clinical remission in RRRR StudyRheumatoid Arthritis
JPRN-UMIN000007539niversity of Occupational and Environmental Health, Japan108